Nimrata Hunt Idexx Laboratories Inc (IDXX) insider trading activity

IDXX Quotes by TradingView

Nimrata Hunt is Executive Vice President of IDEXX LABORATORIES INC . Currently has a direct ownership of 21,148 shares of IDXX, which is worth approximately $14.6 Million. The most recent transaction as insider was on Nov 07, 2025, when has been sold 9,425 shares (Common Stock) at a price of $704.08 per share, resulting in proceeds of $6,635,954. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.1K
17.28% 3M change
81.12% 12M change
Total Value Held $14.6 Million

Nimrata Hunt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 07 2025
SELL
Open market or private sale
$6,635,954 $704.08 p/Share
9,425 Reduced 30.83%
21,148 Common Stock
Nov 07 2025
BUY
Exercise of conversion of derivative security
$4,976,289 $397.15 p/Share
12,530 Added 29.07%
30,573 Common Stock
Aug 12 2025
BUY
Exercise of conversion of derivative security
$379,765 $309.76 p/Share
1,226 Added 6.37%
18,032 Common Stock
Aug 11 2025
SELL
Open market or private sale
$787,836 $656.53 p/Share
1,200 Reduced 6.66%
16,806 Common Stock
Aug 06 2025
SELL
Open market or private sale
$4,503,590 $630.49 p/Share
7,143 Reduced 28.4%
18,006 Common Stock
Aug 06 2025
BUY
Exercise of conversion of derivative security
$2,246,626 $175.6 p/Share
12,794 Added 33.72%
25,149 Common Stock
Feb 14 2025
SELL
Payment of exercise price or tax liability
$119,134 $444.53 p/Share
268 Reduced 2.13%
12,327 Common Stock
Feb 14 2025
BUY
Exercise of conversion of derivative security
-
872 Added 6.48%
12,595 Common Stock
Feb 14 2024
SELL
Payment of exercise price or tax liability
$147,427 $560.56 p/Share
263 Reduced 2.2%
11,676 Common Stock
Feb 14 2024
BUY
Grant, award, or other acquisition
-
208 Added 1.71%
11,939 Common Stock
Feb 14 2024
BUY
Exercise of conversion of derivative security
-
664 Added 5.36%
11,731 Common Stock
Feb 14 2023
SELL
Payment of exercise price or tax liability
$120,372 $503.65 p/Share
239 Reduced 2.12%
11,015 Common Stock
Feb 14 2023
BUY
Exercise of conversion of derivative security
-
791 Added 6.57%
11,254 Common Stock
Feb 09 2023
BUY
Exercise of conversion of derivative security
$99,969 $141.6 p/Share
706 Added 6.32%
10,463 Common Stock
Feb 14 2022
SELL
Payment of exercise price or tax liability
$103,128 $505.53 p/Share
204 Reduced 2.06%
9,702 Common Stock
Feb 14 2022
BUY
Exercise of conversion of derivative security
-
675 Added 6.38%
9,906 Common Stock
Aug 10 2021
BUY
Exercise of conversion of derivative security
$115,831 $104.73 p/Share
1,106 Added 10.72%
9,212 Common Stock
Aug 05 2021
SELL
Open market or private sale
$378,214 $703.0 p/Share
538 Reduced 6.22%
8,106 Common Stock
Aug 05 2021
BUY
Exercise of conversion of derivative security
$56,345 $104.73 p/Share
538 Added 5.86%
8,644 Common Stock
Feb 14 2021
SELL
Payment of exercise price or tax liability
$117,521 $544.08 p/Share
216 Reduced 2.6%
8,083 Common Stock
Feb 14 2021
BUY
Exercise of conversion of derivative security
-
714 Added 7.92%
8,299 Common Stock
Nov 05 2020
SELL
Open market or private sale
$986,228 $470.08 p/Share
2,098 Reduced 21.7%
7,571 Common Stock

Also insider at

VEEV
VEEVA SYSTEMS INC Healthcare
Director
NH

Nimrata Hunt

Executive Vice President
Pleasanton, CA

Track Institutional and Insider Activities on IDXX

Follow IDEXX LABORATORIES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDXX shares.

Notify only if

Insider Trading

Get notified when an Idexx Laboratories Inc insider buys or sells IDXX shares.

Notify only if

News

Receive news related to IDEXX LABORATORIES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IDXX